Mesenchymal stem cell‐derived extracellular vesicles for the treatment of acute respiratory distress syndrome
Abstract Acute respiratory distress syndrome (ARDS) is a serious and potentially fatal acute inflammatory lung condition which currently has no specific treatments targeting its pathophysiology. However, mesenchymal stem cells have been shown to have very promising therapeutic potential, and recentl...
Main Authors: | Aswin Abraham, Anna Krasnodembskaya |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Stem Cells Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/sctm.19-0205 |
Similar Items
-
The effect of acute respiratory distress syndrome on bone marrow-derived mesenchymal stem cells
by: Ben Antebi, et al.
Published: (2018-09-01) -
Research Progress on Strategies that can Enhance the Therapeutic Benefits of Mesenchymal Stromal Cells in Respiratory Diseases With a Specific Focus on Acute Respiratory Distress Syndrome and Other Inflammatory Lung Diseases
by: Sara Rolandsson Enes, et al.
Published: (2021-04-01) -
Genetically modified mesenchymal stem cell therapy for acute respiratory distress syndrome
by: Jibin Han, et al.
Published: (2019-12-01) -
Umbilical cord mesenchymal stem cells for COVID‐19 acute respiratory distress syndrome: A double‐blind, phase 1/2a, randomized controlled trial
by: Giacomo Lanzoni, et al.
Published: (2021-05-01) -
Mesenchymal and Induced Pluripotent Stem Cells-Derived Extracellular Vesicles: The New Frontier For Regenerative Medicine?
by: Maria Magdalena Barreca, et al.
Published: (2020-05-01)